Acurx Pharmaceuticals ACXP Earnings Call Transcripts

NASDAQ ACXP
$1.08 +0.02 (+1.89%)
As of: Nov 10, 2026 · 10:09 AM EST
1 earnings call on file for Acurx Pharmaceuticals, Q1 2026. Each transcript opens in a new tab.
Latest earnings call

Acurx Pharmaceuticals Q1 2026 Earnings Call

May 12, 2026 3,868 words · 17 min read
  • David P. LuciPresident & Chief Executive Officer
  • Robert J. ShawahChief Financial Officer
  • Robert J. DeLucciaExecutive Chairman
  • Michael A. SilvermanMedical Director
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Acurx Pharmaceuticals Earnings Call Transcripts

Calls1
LatestMay 12, 2026
SinceQ1 2026

Fiscal 2026

All 1 Acurx Pharmaceuticals transcript Register to get access to Acurx Pharmaceuticals’s earnings call transcripts.